Ann Clin Microbiol.  2018 Mar;21(1):20-22. 10.5145/ACM.2018.21.1.20.

Campylobacter fetus Peritonitis in a Patient with Continuous Ambulatory Peritoneal Dialysis: A First Case Report in Korea

• Hur K
• Lee E
• Kang J
• Lee Y

• KMID: 2414121
• DOI: http://doi.org/10.5145/ACM.2018.21.1.20

Abstract

Campylobacter fetus may cause infections such as septicemia, peritonitis, meningitis, endocarditis, septic arthritis, and cellulitis, increasing the risk of spontaneous abortion but decreasing the likelihood of gastroenteritis. We identified C. fetus from continuous ambulatory peritoneal dialysis (CAPD) fluid using 16S rRNA gene sequencing. It is significant that this is the first case report in Korea of CAPD peritonitis caused by C. fetus, which is known to be rare.

Keyword

Campylobacter fetus; Continuous ambulatory peritoneal dialysis; Peritonitis; 16S rRNA

MeSH Terms

Abortion, Spontaneous
Arthritis, Infectious
Campylobacter fetus*
Campylobacter*
Cellulitis
Endocarditis
Female
Fetus
Gastroenteritis
Genes, rRNA
Humans
Korea*
Meningitis
Peritoneal Dialysis, Continuous Ambulatory*
Peritonitis*
Pregnancy
Sepsis

Reference

References

1. Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 12nd ed.St. Louis: Mosby;2007. p. 418–20.

2. Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun-Buisson C, et al. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis. 2008; 27:185–9.

3. Elshafie SS, Asim M, Ashour A, Elhiday AH, Mohsen T, Doiphode S. Campylobacter peritonitis complicating continuous ambulatory peritoneal dialysis: report of three cases and review of the literature. Perit Dial Int. 2010; 30:99–104.

4. Kim US, Shin JI, Shin JW, Kim SG, Kim YS, Oh MD, et al. A case of septic pneumonia secondary to community: acquired Campylobacter fetus bacteremia. Korean J Infect Dis. 2002; 34:73–7.

5. Romero Gómez MP, García-Perea A, Ruiz Carrascoso G, Bajo MA, Mingorance J. Campylobacter fetus peritonitis and bacteremia in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol. 2010; 48:336–7.

6. Kubota M, Ishiguro N, Tomino Y, Koide H. Campylobacter fetus subspecies fetus peritonitis in continuous ambulatory peritoneal dialysis. Nephron. 1993; 65:487–8.

7. Wood CJ, Fleming V, Turnidge J, Thomson N, Atkins RC. Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis. 1992; 19:257–63.

8. Wens R, Dratwa M, Potvliege C, Hansen W, Tielemans C, Collart F. Campylobacter fetus peritonitis followed by septicaemia in a patient on continuous ambulatory peritoneal dialysis. J Infect. 1985; 10:249–51.

9. CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline. CLSI document M45-A2. Wayne, PA: Clinical and Laboratory Standards Institute;2010.

10. Chong YS, Lee KW, et al. eds. Current Diagnostic Microbiology. 4th ed.Seoul: Seo Heung Press;2009. p. 355–7.

11. Longo DI, Fauci AS, et al. Harrison's Principles of Internal Medicine. 19th ed.New York: McGraw-Hill;2015. p. 1058–61.

12. Cho IJ, Yim J, Lee Y, Kim MS, Seo Y, Chung HS, et al. Trends in isolation and antimicrobial susceptibility of enteropathogenic bacteria in 2001–2010 at a Korean tertiary care hospital. Ann Clin Microbiol. 2013; 16:45–51.

13. Kim SM, Kim EC, Choi MR, So HA, Shim ES, Kim ES, et al. Cytolethal distending toxin production, genotypes and atimicrobial susceptibility of Campylobacter jejuni isolates from diarrhea patients and chickens. J Bacteriol Virol. 2008; 38:207–19.

14. Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl. 2006; 103:S44–54.